Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27492-84-8

Post Buying Request

27492-84-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • China Biggest factory Supply High Quality Methyl 4-amino-2-methoxybenzoate CAS 27492-84-8

    Cas No: 27492-84-8

  • USD $ 1.0-5.0 / Kilogram

  • 1 Kilogram

  • 1000 Kilogram/Day

  • Leader Biochemical Group
  • Contact Supplier

27492-84-8 Usage

Chemical Properties

Grey Solid

Uses

Different sources of media describe the Uses of 27492-84-8 differently. You can refer to the following data:
1. An intermediate in the synthesis of Metoclopramide.
2. An intermediate in the synthesis of Metoclopramide

Check Digit Verification of cas no

The CAS Registry Mumber 27492-84-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,4,9 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 27492-84:
(7*2)+(6*7)+(5*4)+(4*9)+(3*2)+(2*8)+(1*4)=138
138 % 10 = 8
So 27492-84-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO3/c1-12-8-5-6(10)3-4-7(8)9(11)13-2/h3-5H,10H2,1-2H3

27492-84-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A13239)  Methyl 4-amino-2-methoxybenzoate, 98%   

  • 27492-84-8

  • 1g

  • 155.0CNY

  • Detail
  • Alfa Aesar

  • (A13239)  Methyl 4-amino-2-methoxybenzoate, 98%   

  • 27492-84-8

  • 5g

  • 286.0CNY

  • Detail
  • Alfa Aesar

  • (A13239)  Methyl 4-amino-2-methoxybenzoate, 98%   

  • 27492-84-8

  • 25g

  • 1214.0CNY

  • Detail

27492-84-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 4-amino-2-methoxybenzoate

1.2 Other means of identification

Product number -
Other names 4-Amino-o-anisic Acid Methyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27492-84-8 SDS

27492-84-8Relevant articles and documents

Copper-catalyzed oxidative methyl-esterification of 5-hydroxymethylfurfural using TBHP as an oxidizing and methylating reagent: A new approach for the synthesis of furan-2,5-dimethylcarboxylate

Gupta, Shyam Sunder R.,Kantam, Mannepalli Lakshmi,Vinu, Ajayan

, p. 259 - 269 (2020/06/27)

Catalytic conversion of 5-hydroxymethylfurfural (HMF) into furan-2,5-dimethylcarboxylate (FDMC) is of great significance in the production of polyethylene furanoate (PEF), a renewable biomass-derived polymer that can replace the fossil dependent polyethylene terephthalate (PET). Herein, for the first time, we report the synthesis of FDMC from oxidative methyl-esterification of HMF using tert-butyl hydroperoxide (TBHP) as an oxidizing and methylating reagent catalyzed by mesoporous alumina nanospheres-embedded with CuO nanoparticles (CuO/m-Al2O3). The CuO/m-Al2O3 catalysts with different copper contents were prepared by evaporation-induced self-assembly of a structure-directing agent (Pluronic P-123). The decomposition of P-123 during calcination in air results into the formation of a mesoporous structure with highly dispersed CuO nanoparticles. The as-prepared 6-CuO/m-Al2O3 exhibits excellent catalytic activity towards oxidative methyl-esterification of HMF into FDMC with 92% yield and turnover frequency (TOF) of 0.56 h?1. Furthermore, oxidative methyl-esterification of a range of substrates through SP3 C[sbnd]H bond functionalization has also been demonstrated using the same catalyst.

Synthetic method of anti-cancer drug lenvatinib

-

Paragraph 0112; 0114-0118; 0148-0154; 0185-0190; 0221-0226, (2018/04/02)

The invention discloses a synthetic method of anti-cancer drug lenvatinib. Lenvatinib is synthesized from the compound p-aminosalicylic acid shown as drawing 1 as a starting material with the method.Reaction conditions are mild, special reaction equipment is not needed, and the applicable range is wider. Raw materials and reagents used in the method are easily purchased from the market, and reduction of production cost is facilitated. The method is simple to operate, short in synthesis period and more suitable for large-scale industrial production of lenvatinib. The method is high in synthesis efficiency, and purity of synthesized lenvatinib is high.

QUINAZOLINE-BASED KINASE INHIBITORS

-

Page/Page column 125, (2016/04/26)

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27492-84-8